Combining PARP inhibitor with TACC3 inhibition overcomes PARP inhibitor resistance in ovarian cancer

被引：0
|
作者：
Wu, Yu
Wang, Qilong
Deng, Chaolin
Li, Mo
Xiao, Yinan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4757
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4757
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] PARP Inhibitor Treatment in Ovarian and Breast Cancer Foreword
    Kummar, Shivaani
    CURRENT PROBLEMS IN CANCER, 2011, 35 (01) : 6 - 6
  • [32] Olaparib: a promising PARP inhibitor in ovarian cancer therapy
    Chen, Ying
    Zhang, Lei
    Hao, Quan
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 288 (02) : 367 - 374
  • [33] Identifying the radiosensitizing effects of PARP inhibitor in ovarian cancer
    Bi, Yue
    Verginadis, Ioannis
    Dey, Souvik
    Guo, Linlang
    Lin, Lilie
    Zheng, Yanfang
    Koumenis, Constantinos
    CANCER RESEARCH, 2017, 77
  • [34] The role of PARP inhibitor combination therapy in ovarian cancer
    Hockings, Helen
    Miller, Rowan E.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [35] Olaparib: a promising PARP inhibitor in ovarian cancer therapy
    Ying Chen
    Lei Zhang
    Quan Hao
    Archives of Gynecology and Obstetrics, 2013, 288 : 367 - 374
  • [36] Olaparib, PARP1 inhibitor in ovarian cancer
    Marchetti, Claudia
    Imperiale, Ludovica
    Gasparri, Maria Luisa
    Palaia, Innocenza
    Pignata, Sandro
    Boni, Terenzio
    Bellati, Filippo
    Panici, Pierluigi Benedetti
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (10) : 1575 - 1584
  • [37] Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer
    Veneziani, Ana C.
    Scott, Clare
    Wakefield, Matthew J.
    Tinker, Anna V.
    Lheureux, Stephanie
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [38] Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?
    Daniel Martin Klotz
    Pauline Wimberger
    Archives of Gynecology and Obstetrics, 2020, 302 : 1087 - 1102
  • [39] Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients
    Senturk Kirmizitas, Tugce
    van den Berg, Caroline
    Boers, Ruben
    Helmijr, Jean
    Makrodimitris, Stavros
    Dag, Hamit Harun
    Kerkhofs, Marijn
    Beaufort, Corine
    Kraan, Jaco
    van IJcken, Wilfred F. J.
    Gribnau, Joost
    Garkhail, Pakriti
    Boer, Gatske Nieuwenhuyzen-de
    Roes, Eva-Maria
    van Beekhuizen, Heleen
    Gunel, Tuba
    Wilting, Saskia
    Martens, John
    Jansen, Maurice
    Boere, Ingrid
    GENES, 2024, 15 (06)
  • [40] Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer
    Veneziani, Ana C.
    Scott, Clare
    Wakefield, Matthew J.
    Tinker, Anna V.
    Lheureux, Stephanie
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
12345